Part I Item 1A. Risk Factors in this Annual Report on Form 10-K. You should carefully consider these risks and uncertainties when investing in our common stock. The principal risks and uncertainties affecting our business include the following: We are a commercial-stage biopharmaceutical company with four products approved for commercial sale. We have incurred significant losses since our inception, and could continue to incur losses, which, together with our limited history as a commercial-stag...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001787306-26-000018 | EDGAR | 101K words |
| 2025-02-25 | 2024-12-31 | 0001787306-25-000029 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0001787306-24-000031 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001787306-23-000023 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001787306-22-000009 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001628280-21-002272 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001787306-20-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001787306-26-000051 | EDGAR | — |
| 2025-10-28 | 2025-09-30 | 0001787306-25-000144 | EDGAR | 23K words |
| 2025-08-06 | 2025-06-30 | 0001787306-25-000124 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001787306-25-000092 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001787306-24-000153 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001787306-24-000124 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001787306-24-000079 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001787306-23-000124 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001787306-23-000077 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001787306-23-000044 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001787306-22-000071 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001787306-22-000051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001787306-26-000049 | EDGAR | — |
| 2026-07-16 | 0001628280-26-048469 | EDGAR | — |
| 2026-02-25 | 0001787306-26-000017 | EDGAR | 3K words |
| 2025-12-08 | 0001787306-25-000147 | EDGAR | — |
| 2025-10-28 | 0001787306-25-000142 | EDGAR | — |
| 2025-08-06 | 0001787306-25-000122 | EDGAR | — |
| 2025-06-17 | 0001787306-25-000096 | EDGAR | — |
| 2025-05-06 | 0001787306-25-000091 | EDGAR | — |
| 2025-04-10 | 0001787306-25-000058 | EDGAR | — |
| 2025-02-25 | 0001787306-25-000028 | EDGAR | — |
121 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001787306 |
| Ticker | ARQT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.arcutis.com |
| Listed | 2020-01-31 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ARQT (~200 tokens, structured JSON with cryptographic provenance)